These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 16403405)

  • 1. Myelodysplastic syndromes clinical practice guidelines in oncology.
    Greenberg PL; Baer MR; Bennett JM; Bloomfield CD; De Castro CM; Deeg HJ; Devetten MP; Emanuel PD; Erba HP; Estey E; Foran J; Gore SD; Millenson M; Navarro WH; Nimer SD; O'Donnell MR; Saba HI; Spiers K; Stone RM; Tallman MS
    J Natl Compr Canc Netw; 2006 Jan; 4(1):58-77. PubMed ID: 16403405
    [No Abstract]   [Full Text] [Related]  

  • 2. Focus on myeloproliferative diseases and myelodysplastic syndromes.
    Van Etten RA; Shannon KM
    Cancer Cell; 2004 Dec; 6(6):547-52. PubMed ID: 15607959
    [No Abstract]   [Full Text] [Related]  

  • 3. [Myelodysplastic diseases in childhood].
    Niemeyer C; Stollmann-Gibbels B; Ebell W; Gaedicke G; Creutzig U
    Klin Padiatr; 1992; 204(4):190-7. PubMed ID: 1518255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is in a name? Refined diagnostic criteria for prognostic assessment in myelodysplastic syndrome (MDS).
    Deeg HJ
    Leuk Res; 2004 Jun; 28(6):543-4. PubMed ID: 15120927
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of pediatric myelodysplastic syndromes and juvenile myelomonocytic leukemia: the Brazilian experience in the past decade.
    Valera ET; Latorre Mdo R; Mendes WL; Seber A; Lee ML; de Paula MJ; Loggetto SR; Velloso E; Niero-Melo L; Lopes LF;
    Leuk Res; 2004 Sep; 28(9):933-9. PubMed ID: 15234570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myelodysplastic syndrome].
    Urabe A
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):287-91. PubMed ID: 15791810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelodysplastic and myeloproliferative disorders in children.
    Hasle H
    Curr Opin Pediatr; 2007 Feb; 19(1):1-8. PubMed ID: 17224655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Myelodysplastic syndromes].
    Ann Biol Clin (Paris); 1985; 43(4):369-79. PubMed ID: 4091300
    [No Abstract]   [Full Text] [Related]  

  • 9. The myelodysplastic syndromes: diagnostic criteria and laboratory evaluation.
    Ho PJ; Gibson J; Vincent P; Joshua D
    Pathology; 1993 Jul; 25(3):297-304. PubMed ID: 8265251
    [No Abstract]   [Full Text] [Related]  

  • 10. Advances in the management of low- to intermediate-risk myelodysplastic syndrome: Integrating the National Comprehensive Cancer Network guidelines.
    Kurtin SE
    Clin J Oncol Nurs; 2006 Apr; 10(2):197-208. PubMed ID: 16708703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelodysplastic syndromes: recent advances.
    Alessandrino EP; Amadori S; Cazzola M; Locatelli F; Mecucci C; Morra E; Saglio G; Visani G; Tura S
    Haematologica; 2001 Nov; 86(11):1124-57. PubMed ID: 11694400
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes.
    American Society for Blood and Marrow Transplantation
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):135-6. PubMed ID: 19167675
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults.
    Zandberg DP; Huang TY; Ke X; Baer MR; Gore SD; Smith SW; Davidoff AJ
    Haematologica; 2013 Apr; 98(4):584-90. PubMed ID: 23144192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating low-risk myelodysplastic syndromes in the community setting.
    Cripe LD
    Clin Adv Hematol Oncol; 2008 Jun; 6(6):418-20. PubMed ID: 18567986
    [No Abstract]   [Full Text] [Related]  

  • 15. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.
    Oliansky DM; Antin JH; Bennett JM; Deeg HJ; Engelhardt C; Heptinstall KV; de Lima M; Gore SD; Potts RG; Silverman LR; Jones RB; McCarthy PL; Hahn T
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):137-72. PubMed ID: 19167676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myelodysplastic syndromes or refractory anemias].
    Fenaux P
    Rev Prat; 1993 Jun; 43(11):1379-85. PubMed ID: 8235387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myelodysplastic syndrome. What can be achieved with supportive therapy and new approaches].
    Bischoff M
    MMW Fortschr Med; 2011 Nov; 153(44):18. PubMed ID: 22111164
    [No Abstract]   [Full Text] [Related]  

  • 19. Myelodysplastic syndromes: disease overview and therapy options.
    Coutré S
    Manag Care; 2008 Jul; 17(7 Suppl 6):3-8. PubMed ID: 19093333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoiesis-stimulating agents versus RBC transfusion in MDS: comparison of long-term outcomes.
    Mundle SD
    Future Oncol; 2007 Aug; 3(4):397-403. PubMed ID: 17661714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.